Carriage Services will release its second quarter 2026 earnings and hold a conference call, with details announced via GlobeNewswire. Key for investors.
Browsing Category
General
113 posts
ASTROTECH Corp Files 8-K: Executive Change
ASTROTECH Corp has filed an 8-K report revealing a significant executive leadership change. Details are confirmed, but reasons remain unclear.
ECB Appoints Boris Kisselevsky As Director General Secretariat
The European Central Bank has appointed Boris Kisselevsky as the new Director General of the Secretariat, effective immediately, in a move to strengthen its administrative leadership.
TransMedics To Report Second Quarter 2026 Financial Results On August 4, 2026
TransMedics will report its second quarter 2026 financial results on August 4, 2026, providing updates on its financial performance and business outlook.
First Community Bankshares, Inc. Announces Record Second Quarter 2026 Results And Quarterly Cash Dividend
First Community Bankshares, Inc. announced its highest-ever second quarter earnings for 2026, driven by strong loan growth and improved net interest margins.
Canadian Life Companies Split Corp. Financial Results To May 31, 2026
Canadian Life Companies Split Corp. announced its financial results for the period ending May 31, 2026, highlighting key earnings and asset changes.
Harmony Biosciences To Report Second Quarter 2026 Financial Results On August 4, 2026
Harmony Biosciences will report its second quarter 2026 financial results on August 4, 2026, the company announced via GlobeNewswire. Details are forthcoming.
HunterLab Launches Vista® L2 With An Extended 710 Nm Measurement Range
HunterLab launches Vista® L2 spectrophotometer featuring an extended 710 nm measurement range, enhancing color analysis capabilities for various industries.
Park Aerospace Corp. Reports First Quarter Results
Park Aerospace Corp. announces its first quarter financial results, showing increased revenue but lower net income amid market challenges.
Fangzhou Launches Novo Nordisk’s Once-Weekly Basal Insulin/GLP-1 Therapy In China
Fangzhou has announced the launch of Novo Nordisk’s once-weekly basal insulin and GLP-1 therapy in China, marking a significant step in diabetes treatment availability.